Adjuvant Tamoxifen Reduces Subsequent Breast Cancer in Women With Estrogen Receptor–Positive Ductal Carcinoma in Situ: A Study Based on NSABP Protocol B-24

PURPOSE: The NSABP (National Surgical Adjuvant Breast and Bowel Project) B-24 study demonstrated significant benefit with adjuvant tamoxifen in patients with ductal carcinoma in situ (DCIS) after lumpectomy and radiation. Patients were enrolled without knowledge of hormone receptor status. The curre...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Allred, D. Craig, Anderson, Stewart J., Paik, Soonmyung, Wickerham, D. Lawrence, Nagtegaal, Iris D., Swain, Sandra M., Mamounas, Elefetherios P., Julian, Thomas B., Geyer, Charles E., Costantino, Joseph P., Land, Stephanie R., Wolmark, Norman
Format: Artigo
Jezik:Inglês
Izdano: American Society of Clinical Oncology 2012
Teme:
Original Reports
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3341142/
https://ncbi.nlm.nih.gov/pubmed/22393101
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2010.34.0141
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki